Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 3Suspended 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Neoplasms 2Cancer Pain 2Squamous Cell Carcinoma of Head and Neck 1Neuralgia 1Mucositis 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Buprenorphine × Clear all
NCT04752384 2025-04-20

Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients

Medical College of Wisconsin

Phase 2 Completed
20 enrolled 10 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Mucositis

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Completed
150 enrolled

Cancer Pain, Neoplasms, Neuralgia

NCT01809106 2015-12-24

CERP

Mario Negri Institute for Pharmacological Research

Phase 4 Completed
518 enrolled 11 charts

Cancer Pain, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡